Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness and safety of atomoxetine in the
treatment of adolescents with coexisting alcohol or substance use disorders and Attention
Deficit Hyperactivity Disorder (ADHD).
Phase:
Phase 2
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)